Apptly Health Technologies signed a partnership with the maker of the only FDA-approved breast CT system on Tuesday. Two days later, on Wednesday, the company’s stock became tradable to a much larger pool of US investors for the first time. The timing wasn’t a coincidence so much as a pattern; it’s roughly the pace the company has kept since a reverse takeover took it public in March.
Apptly Gains OTCQB Listing and DTC Eligibility, Broadening US Investor Access
Apptly Health Technologies Corp. (CSE: APPT) (OTCQB: ESVNF), operator of the UberDoc direct-pay healthcare marketplace, announced on September 2 that its common shares have been approved to trade on the OTCQB Venture Market in the United States under the symbol ESVNF, and confirmed DTC eligibility, allowing the shares to be electronically cleared and settled through the Depository Trust Company. The company continues to trade on the Canadian Securities Exchange under the ticker APPT; the OTCQB listing runs alongside the CSE listing rather than replacing it. Together, these two changes are aimed squarely at US investors, who previously faced more friction buying and settling shares in a CSE-only listing.
Founder and CEO Dr. Paula Muto framed the listing as removing a barrier to entry at what she called an important point in the company’s growth. That framing is standard for this kind of announcement, but the underlying mechanics are real: OTCQB trading and DTC eligibility typically widen the pool of US brokerages and investors who can hold and trade a stock without extra paperwork, which can meaningfully improve liquidity for a small, thinly traded name.
A Day Earlier, UberDoc Added an FDA-Approved Breast Imaging Partner
The listing news followed a September 1 announcement that UberDoc had signed a strategic partnership with Koning Corporation, maker of the Koning Vera Breast CT, the only breast CT system with FDA premarket approval for diagnostic breast imaging. The device performs non-compression 3D breast imaging, an alternative to standard mammography that avoids compressing the breast during the scan. Under the partnership, UberDoc adds Koning’s imaging sites to its marketplace, listing breast CT scans at transparent, upfront prices the way it already does for its network of specialists.
This is currently only an intent to establish revenue sharing. The methodology and specific terms have not yet been agreed, Apptly has not attributed any revenue to the arrangement, and there is no assurance a revenue-sharing agreement will ultimately be concluded. That’s a meaningfully softer commitment than a signed commercial contract with defined economics, and it’s worth reading the partnership with that distinction in mind rather than as an immediate revenue driver.
The Platform Behind the Partnerships
UberDoc’s pitch is straightforward: patients book board-certified specialists directly, at transparent upfront prices, without needing a referral or navigating insurance pre-authorization. The platform lists more than 5,000 specialist physicians and clinicians across more than 55 specialties in all 50 US states. The Koning deal is the latest in a fairly steady cadence of partnership and network announcements this year: an Emphera Health partnership in June added roughly 2,000 specialists to the network, a July partnership brought women’s health company Bryleos onto the marketplace, and the company expanded its advisory board over the summer, including adding Lemonaid Health co-founder Paul Johnson.
A Recent Public Listing With a Shell Company Past
Apptly’s public listing history is worth knowing before reading too much into any single announcement. The company began trading on the CSE under the ticker APPT in March 2026, after completing a reverse takeover of ROV Investment Partners Corp, itself a renamed version of Serra Energy Metals Corp, a mining shell company. The company operated as UberDoc Health Technologies Corp. before rebranding to Apptly Health Technologies in June 2026. Companies that go public through a reverse takeover of a dormant shell skip the traditional IPO scrutiny process, and Apptly has not disclosed meaningful revenue figures in any of the releases reviewed for this article. None of that makes the underlying UberDoc business illegitimate, but it does mean the company is still early in proving out a durable, monetized business model rather than simply accumulating partnership announcements.
What to Watch
Whether the Koning partnership’s revenue-sharing terms actually get finalized, and on what basis, is the concrete next step that would move this from an announced intent to a real commercial relationship. Whether the OTCQB listing meaningfully improves trading volume and liquidity for a stock that has, to date, traded primarily on the CSE will also become clearer over the coming weeks. Apptly’s pace of announcements suggests more partnership news is likely; the more useful signal for investors will be whether any of these relationships eventually show up as disclosed revenue rather than as another press release.
Sources
- StockTitan: Apptly Commences Trading on the OTCQB and Becomes DTC Eligible, September 2, 2026
- Health Technology Net: Apptly and Koning Announce Strategic Partnership to Expand Patient Access to Non-Compression 3D Breast Imaging, September 1, 2026
- Kalkine: Apptly Health Technologies Corp Approved for OTCQB Trading and Achieves DTC Eligibility, September 2, 2026
- BusinessWire: UBERDOC Health Technologies Corp. to Begin Trading on the Canadian Securities Exchange Under the Symbol APPT, March 2026
Editorial Disclosure
This article is based entirely on publicly available information including company press releases and news coverage. The security discussed is Apptly Health Technologies Corp. (CSE: APPT) (OTCQB: ESVNF) (FSE: 4KL0), formerly UBERDOC Health Technologies Corp. and, prior to its reverse takeover, Serra Energy Metals Corp. aktiego.com has not received any compensation from Apptly Health Technologies, its management, investor relations representatives, or any third party. No staff member or principal of aktiego.com holds a position in this security at the time of publication.
The Koning Corporation partnership is currently an intent to establish revenue sharing only; the methodology and specific terms have not been agreed, Apptly has not attributed any revenue to the arrangement, and there is no assurance a revenue-sharing agreement will be concluded, per the companies’ own joint disclosure. Apptly became publicly traded via a reverse takeover of a dormant mining shell company in March 2026, a listing method that does not carry the same regulatory scrutiny as a traditional initial public offering. aktiego.com did not identify disclosed revenue figures for Apptly in the sources reviewed for this article; readers should not assume the company is currently profitable or revenue-generating based on this coverage. OTCQB Venture Market listing and DTC eligibility are administrative and market-access changes; they do not constitute an endorsement of the company by any regulator or exchange and do not guarantee improved trading liquidity.Small cap and micro-cap stocks listed on the CSE, TSX, TSXV, and Nasdaq are speculative investments carrying significant risk including potential total loss of capital. Coverage on aktiego.com is provided for informational and educational purposes only. aktiego.com is not a registered investment advisor. Nothing in this article constitutes financial, investment, or professional advice. Readers are encouraged to conduct their own due diligence and consult a qualified financial advisor before making any investment decisions. For more information please see our full DISCLAIMER at
